- Vaccine Name: Synflorix
- Target Pathogen: Streptococcus pneumoniae
- Target Disease: Pneumonia
- Product Name: Pneumococcal conjugate vaccine (Non-Typeable Haemophilus influenzae (NTHi) protein D, diphtheria or tetanus toxoid conjugates) adsorbed
- Tradename: Synflorix
- Manufacturer: GlaxoSmithKline Inc.
- Vaccine Ontology ID: VO_0001245
- Type: Conjugate vaccine
- Status: Licensed
- Location Licensed: Canada
- Host Species for Licensed Use: Human
- Antigen: Pneumococcal polysaccharides of serotypes 1,4,5,6B,7F,9V,14,18C,19F,23F (GSK: Synflorix).
- Adjuvant:
- Immunization Route: Intramuscular injection (i.m.)
- Storage: Store in a refrigerator (2°C - 8°C).
- Approved Age for Licensed Use: Infants and children from 6 weeks up to 2 years of age (GSK: Synflorix).
- Description: SYNFLORIX™ [(pneumococcal conjugate vaccine (Non-Typeable Haemophilus influenzae (NTHi) protein D, diphtheria or tetanus toxoid conjugates) adsorbed] is a 10- valent pneumococcal polysaccharide conjugate vaccine using protein D derived from Non-Typeable Haemophilus influenzae as a carrier protein for 8 out of the 10 serotypes (1, 4, 5, 6B, 7F, 9V, 14 and 23F). Serotypes 18C and 19F are conjugated to tetanus toxoid and to diphtheria toxoid, respectively. All conjugates are adsorbed onto aluminum phosphate (GSK: Synflorix).
|
